Treatment of familial erythromelalgia with venlafaxine
- 12 June 2007
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 21 (6) , 836-837
- https://doi.org/10.1111/j.1468-3083.2006.02039.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neuronsBrain, 2005
- SCN9A Mutations Define Primary Erythermalgia as a Neuropathic Disorder of Voltage Gated Sodium ChannelsJournal of Investigative Dermatology, 2005
- Erythromelalgia: A hereditary pain syndrome enters the molecular eraAnnals of Neurology, 2005
- Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgiaJournal of Medical Genetics, 2004
- Treatment of erythromelalgia with a serotonin/noradrenaline reuptake inhibitorBritish Journal of Dermatology, 2002
- The Primary Erythermalgia–Susceptibility Gene Is Located on Chromosome 2q31-32American Journal of Human Genetics, 2001
- Erythromelalgia: Response to serotonin reuptake inhibitorsJournal of the American Academy of Dermatology, 1997